Hostname: page-component-76fb5796d-qxdb6 Total loading time: 0 Render date: 2024-04-25T16:11:45.859Z Has data issue: false hasContentIssue false
  • English
  • Français

Detection of occult nasopharyngeal primary tumours by means of in situ hybridization

Published online by Cambridge University Press:  29 June 2007

R. Feinmesser ,
M. Feinmesser ,
J. L. Freeman ,
A. M. Noyek  and
N. Livni
R. Feinmesser*
Affiliation:
Department of Otolaryngology, Mount Sinai Hospital, University of Toronto, Toronto, Canada.
M. Feinmesser
Affiliation:
Deparment of Pathology, Hadassah Medical Centre, The Hebrew University, Jerusalem, Israel.
J. L. Freeman
Affiliation:
Department of Otolaryngology, Mount Sinai Hospital, University of Toronto, Toronto, Canada.
A. M. Noyek
Affiliation:
Department of Otolaryngology, Mount Sinai Hospital, University of Toronto, Toronto, Canada.
N. Livni
Affiliation:
Deparment of Pathology, Hadassah Medical Centre, The Hebrew University, Jerusalem, Israel.
*
Dr R. Feinmesser, Head, Department of ENT, Beilinson Medical Centre, Sackler School of Medicine, Tel-Aviv University, 49100 Petah-Tiqva, Israel.
Get access Rights & Permissions [Opens in a new window]

Abstract

Detection of nasopharyngeal carcinoma primaries in patients presenting with neck node metastases may sometimes demand considerable efforts. By using the ‘ in situ hybridization’ technique, wemanage to identify the Epstein-Barr virus in neck metastases secondary to nasopharyngeal carcinomas. We propose that such identification in neck node metastases where the primary lesion is unknown indicates a nasopharyngeal primary.

Keywords

Nasopharyngeal neoplasmsNeoplasms, unknown primaryHybridization
Type
Main Articles
Information
The Journal of Laryngology & Otology , Volume 106 , Issue 4 , April 1992 , pp. 345 - 348
Copyright
Copyright © JLO (1984) Limited 1992

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Chan, M. K. M, Huang, D. W. S. P., Ho, Y. H., Lee, J. C. K. (1989a) Detection of Epstein-Barr virus-associated antigen in fine needle aspiration smears from cervical lymph nodes in the diagnosis of nasopharyngeal carcinoma. Ada Cytologica, 38: 350.Google Scholar
Chan, M. K. M., McGuire, L. J., Lee, J. C. K. (1989 b) Fine needle aspiration cytodiagnosis of nasopharyngeal carcinoma in cervical lymph nodes. A study of 40 cases. Ada Cytologica, 33: 344–350.Google Scholar
Hawkins, E. P., Krischer, J. P., Smith, B. E., Hawkins, H. K., Finegold, M. J. (1990) Nasopharyngeal carcinoma in children—a retrospective review and demonstration of Epstein-Barr viral genomes in tumour cell cytoplasm: A report of the pediatric oncology group. Human Pathology, 21: 805–820.Google Scholar
Henle, W., Ho, J. H. C, Henle, G., Kwan, H. C. (1973) Antibodies to Epstein-Barr virus related antibodies in nasopharyngeal carcinoma. Comparison of active cases and long term survivors. Journal of the National Cancer Institute, 51: 361–369.Google Scholar
Henle, W., Ho, J. H. C, Henle, G., Chou, J. C. W., Kwan, H. C. (1977) Nasopharyngeal carcinoma: Significance of changes in Epstein-Barr virus related antibody patterns following therapy. International Journal of Cancer, 20: 663–672.CrossRefGoogle ScholarPubMed
Neel, H. B., Pearson, G. R., Weiland, L. H., Taylor, W. E, and Goepfert, H. H. (1981) Immunologicdetection of occult primary cancer of the head and neck. Otolaryngology—Head and Neck Surgery, 89: 230–234.CrossRefGoogle ScholarPubMed
Tarr, K. L., Glaser, R. (1989) The Epstein-Barr virus and nasopharyngeal carcinoma. Microbial Pathogenesis, 7: 11–14.Google Scholar
Wolf, H., zur Hausen, H., Becker, V. (1973) EB virus genomes in epithelial nasopharyngeal carcinoma cells. Nature, 244: 245–247.Google Scholar
Zhang, H. Y., Qu, Z. W., Deng, T. H., Yao, T. H., Glaser, R. (1989) Epstein-Barr virus DNA in nasopharyngeal biopsies. Virus Research, 12: 53–60.CrossRefGoogle ScholarPubMed